Alpha Omega Wealth Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-12
Closed -$1K 232
2019
Q2
$1K Sell
12
-18
-60% -$770 ﹤0.01% 587
2019
Q1
$1K Hold
30
﹤0.01% 544
2018
Q4
$1K Hold
30
﹤0.01% 454
2018
Q3
$2K Sell
30
-25
-45% -$1.61K ﹤0.01% 449
2018
Q2
$3K Buy
55
+37
+206% +$1.96K ﹤0.01% 451
2018
Q1
$1K Hold
18
﹤0.01% 468
2017
Q4
$1K Hold
18
﹤0.01% 445
2017
Q3
$1K Hold
18
﹤0.01% 447
2017
Q2
$1K Sell
18
-25
-58% -$945 ﹤0.01% 434
2017
Q1
$2K Sell
43
-12
-22% -$468 ﹤0.01% 431
2016
Q4
$2K Buy
+55
New +$1.97K ﹤0.01% 417

Other funds holding AVNS

Alpha Omega Wealth Management's AVNS Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 12 shares — an estimated $1K sold.

Alpha Omega Wealth Management first reported a position in AVNS in Q4 2016 and held it in 11 quarters. The position peaked at $3K in Q2 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Alpha Omega Wealth Management reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
  • Alpha Omega Wealth Management sold 12 Avanos Medical shares in Q3 2019, an estimated $1K.
  • Alpha Omega Wealth Management first reported a position in Avanos Medical in Q4 2016 and held it in 11 quarters.
  • Alpha Omega Wealth Management's Avanos Medical position peaked at $3K in Q2 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.